DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Attia S, Eickhoff J, Wilding G, McNeel D, Blank J, Ahuja H, Jumonville A, Eastman M, Shevrin D, Glode M.
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.
Clin Cancer Res 2008;
14: 2437-2443
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.